APA

Manzari M. T., Anderson G. R., Lin K. H., Soderquist R. S., Çakir M., Zhang M., Moore C. E., Skelton R. N., Fèvre M., Li X., Bellucci J. J., Wardell S. E., Costa S. A., Wood K. C. & Chilkoti A. (20200514). Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models. : Science advances.

Chicago

Manzari Mandana T, Anderson Gray R, Lin Kevin H, Soderquist Ryan S, Çakir Merve, Zhang Mitchell, Moore Chandler E, Skelton Rachel N, Fèvre Maréva, Li Xinghai, Bellucci Joseph J, Wardell Suzanne E, Costa Simone A, Wood Kris C and Chilkoti Ashutosh. 20200514. Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models. : Science advances.

Harvard

Manzari M. T., Anderson G. R., Lin K. H., Soderquist R. S., Çakir M., Zhang M., Moore C. E., Skelton R. N., Fèvre M., Li X., Bellucci J. J., Wardell S. E., Costa S. A., Wood K. C. and Chilkoti A. (20200514). Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models. : Science advances.

MLA

Manzari Mandana T, Anderson Gray R, Lin Kevin H, Soderquist Ryan S, Çakir Merve, Zhang Mitchell, Moore Chandler E, Skelton Rachel N, Fèvre Maréva, Li Xinghai, Bellucci Joseph J, Wardell Suzanne E, Costa Simone A, Wood Kris C and Chilkoti Ashutosh. Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models. : Science advances. 20200514.